George Rodgers, III, MD, PhD, emphasized that antithrombin III’s expanded pediatric label provides "a sterile, plasma-derived product that will specifically correct the deficiency in a more safe fashion."
George M. Rodgers, III, MD, PhD
Advertisement
George M. Rodgers, M.D., Ph.D. is a Professor of Medicine in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine at the University of Utah School of Medicine.
Articles by George M. Rodgers, III, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
George Rodgers, III, MD, discusses antithrombin III's rare blood-clotting disorder expanded label
2
Transforming teen obesity care: How integrated specialty pharmacy models expand GLP-1 access
3
Daniele De Luca, MD, discusses zelpultide alfa in neonates at high risk of bronchopulmonary dysplasia development
4
